Skip to Main Content

Sima Jeha, MD

Member, St. Jude Faculty

Director, Eastern Mediterranean Region, St. Jude Global

On this page:

Contact Information

Sima Jeha, MD

Global Pediatric Medicine

MS 721, Room S2034

St. Jude Children's Research Hospital

262 Danny Thomas Place

MemphisTN

Education

MD – American University of Beirut, Lebanon

Honors & Awards

  • 2011-2012 Best Doctors in America
  • 2011 The Evidence-Based Practice (EBP)/Research Council Spotlight Award, St. Jude Children’s Research Hospital
  • 2009 AACR Team Science Award
  • 1996 PRS Research Award, Testing novel therapeutic approaches in a SCID mouse model of human leukemia, UT M. D. Anderson Cancer Center
  • 1991 Clinical Trainees Research Award, UT M. D. Anderson Cancer Center

Research Interests

  • Developmental therapeutics
  • Protocol development and clinical investigations in leukemia
  • Relapsed and refractory leukemia
  • Leukemia in the adolescent and young adult

Clinical Trials

Recruiting
INOMRD: Inotuzumab Ozogamicin for High-Risk B-Cell Acute Lymphoblastic Leukemia

Study goal:

The main goal of this study is to learn about the good and bad side effects of inotuzumab ozogamicin in children with this type of leukemia and to find out how well the drug works to get rid of the disease.

Age:

Younger than 22 years old

St. Jude Publications